Kaleido Biosciences, Inc.

/Kaleido Biosciences, Inc.

We are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.


Price Range
$20.00 - $22.00

Final Shares

Effective Date
February 28, 2019


To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange